A case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors

JAMA Dermatol. 2013 Feb;149(2):243-5. doi: 10.1001/jamadermatol.2013.1073.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adamantane / adverse effects
  • Adamantane / analogs & derivatives*
  • Adamantane / therapeutic use
  • Aged
  • Aged, 80 and over
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Nitriles / adverse effects*
  • Nitriles / therapeutic use
  • Pemphigoid, Bullous / chemically induced*
  • Pemphigoid, Bullous / pathology
  • Pyrrolidines / adverse effects*
  • Pyrrolidines / therapeutic use
  • Severity of Illness Index
  • Vildagliptin

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Nitriles
  • Pyrrolidines
  • Vildagliptin
  • Adamantane